Zacks Investment Research
27 May 2026, 17:46 UTC · 3h ago
Source · https://www.zacks.com/stock/news/2927791/looking-for-a-growth-stock-3-reasons-why-globus-medical-gmed-is-a-solid-choice?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_11_growth-2927791
Read source
Search tags
Story key points
3 claims · impact-rated
Globus Medical (GMED) is projected to have an EPS growth of 19.1% this year, significantly exceeding the industry average of 10.7%. — Strong earnings growth relative to peers is a primary driver for stock price appreciation in growth-oriented equities.
+0.40Zacks Equity Research has assigned Globus Medical a top Zacks Rank and a favorable Growth Style Score. — Positive analyst ratings and quantitative scores from a recognized research firm can increase buying interest.
+0.20Globus Medical currently maintains a sales-to-total-assets (S/TA) ratio of 0.6. — Asset utilization is a secondary efficiency metric that provides limited immediate price movement compared to earnings.
+0.10Impact vectors
1 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Ticker attribution
Model heads
The company is explicitly recommended as a top growth stock with a Strong Buy/Buy rank and projected earnings growth that crushes the industry average.
No ticker relationship head found.
